Why is Nephro Care falling/rising?

As of 09-Sep, Nephro Care India Ltd is currently priced at 166.35, reflecting a decrease of 0.6, or 0.36%. The stock has underperformed its sector by 0.35% today, despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a modest gain of 0.33%, but it has significantly underperformed the benchmark Sensex, which rose by 1.18% in the same period. Additionally, there has been a decline in investor participation, with delivery volume falling by 13.42% compared to the 5-day average, indicating reduced trading interest. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Nephro Care's performance over the last month shows a substantial increase of 19.59%, contrasting sharply with the Sensex's more modest gain of 2.07%. However, the year-to-date performance reveals a decline of 9.59% for Nephro Care, while the Sensex has increased by 5.18%. This disparity highlights the stock's struggle to keep pace with the broader market trends, particularly in the longer term, where it has decreased by 36.54% over the past year compared to a slight decline of 0.27% in the Sensex. Overall, the combination of underperformance relative to the sector and declining investor participation suggests a challenging environment for Nephro Care India Ltd.